Selective binding of the truncated form of the chemokine CKβ8 (25-99) to CC chemokine receptor 1 (CCR1)
Author
Berkhout, Theo
Gohil, Jayneeta
Gonzalez, Pilar
Nicols, Charlotte L.
Moores, Kitty E.
MacPhee, Colin H.
White, John R.
Groot, Pieter H. E.
Attention
2299/13702
Abstract
Human CC chemokine receptor 1 (CCR1) has been proposed as a receptor for CKβ8. To obtain conclusive evidence, binding-displacement studies of 125I-CKβ8 (25-99) were performed on membranes of Chinese hamster ovary cells expressing human CCR1. The IC50 for displacement of 125I-CKβ8 (25-99) with CKβ8 (25-99) was 0.22 nM. The longer forms of CKβ8 (24-99 and 1-99) also displaced 125I-CKβ8, with IC50 values of 6.5 and 16 nM, respectively. Displacement profiles of 125I-CKβ8 (25-99) on freshly prepared human monocytes indicated that CCR1 was the major receptor for CKβ8. We conclude that CCR1 is a receptor for different-length CKβ8 and that CKβ8 (25-99) has a similar affinity for CCR1 as macrophage inflammatory protein-1α (MIP-1α). The longer variants of CKβ8 are significantly less potent than CKβ8 (25-99) and MIP-1α on CCR1 and monocytes (P < 0.05). Copyright (C) 2000 Elsevier Science Inc.
Publication date
2000-03-01Published in
Biochemical PharmacologyPublished version
https://doi.org/10.1016/S0006-2952(99)00354-8Other links
http://hdl.handle.net/2299/13702Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact
Braoudaki, Maria; Ahmad, Mohammed Saqif; Mustafov, Denis; Seriah, Sara; Siddiqui, Mohammad Naseem; Siddiqui, Shoib (2022-10-13)Colorectal cancer (CRC) is considered the second cause of cancer death worldwide. The early diagnosis plays a key role in patient prognosis and subsequently overall survival. Similar to several types of cancer, colorectal ... -
CCR2: Characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach
Berkhout, Theo; Blaney, F.E.; Bridges, A.M.; Cooper, D.G.; Forbes, I.T.; Gribble, A.D.; Groot, P.H.E.; Hardy, A.; Ife, R.J.; Kaur, R.; Moores, K.E.; Shillito, H.; Willetts, J.; Witherington, J. (2003-09-11)We describe here a classical molecular modeling exercise that was carried out to provide a basis for the design of novel antagonist ligands of the CCR2 receptor. Using a theoretical model of the CCR2 receptor, docking ... -
Novel chemokine receptor inhibition assay
School of Life and Medical Sciences; Department of Pharmacy; Health & Human Sciences Research Institute; Medicinal and Analytical Chemistry; Berkhout, Theo; Groot, P. H. E.; Elshourbagy, Nabil; Bergsma, Derek; White, John R. (1998)Ligands MCP-4, MCP-3, RANTES, MCP-2, MCP-1 or eotaxin, has been identified for the G-protein receptor HGBER32.